Molecular Diagnostics

NEW PROGRAM: Respiratory Pathogens Molecular (Launch Quarter 2 / 2026 )

For information on the program, material used, analytical parameters and the frequency of implementation, please refer to the current catalog.

Respiratory Pathogens Molecular

RESPM

Program: RESPM: 2 surveys/year x 3 samples
Material: Liquid or lyophilized samples containing human epithel cells or fibroblasts as control for positive nucleic acid extraction and amplification. Positive samples contain the whole genome of inactivated pathogens, thus covering all possible gene targets used in different NAT/PCR assays (minimum 1 mL).
Evaluation: Qualitative

Analytical parameters:
Adenovirus Bordetella parapertussis
Coronavirus 229EBordetella pertussis
Coronavirus HKU1Chlamydia pneumoniae
Coronavirus NL63 Haemophilus influenzae
Coronavirus OC43Legionella pneumophila
SARS‑CoV‑2 (COVID‑19) Mycoplasma pneumoniae
Influenza AStreptococcus pneumoniae
Influenza B
Human Rhinovirus/Enterovirus
Human Metapneumovirus
Parainfluenza virus

Instructions for Use

IFU_RESPM

Result Entry Form

Entry_result_form_RESPM